<DOC>
	<DOCNO>NCT00002282</DOCNO>
	<brief_summary>To compare efficacy , safety , tolerance fluconazole single daily capsule 14 day versus clotrimazole troche 5 x daily 14 day treatment oropharyngeal candidiasis patient AIDS .</brief_summary>
	<brief_title>A Comparison Safety Effectiveness Fluconazole Clotrimazole Treatment Fungal Infections Mouth Throat Patients With AIDS</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Candidiasis , Oral</mesh_term>
	<mesh_term>Fluconazole</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Cimetidine . Exclusion Criteria Coexisting Condition : Patients follow excluded : Known history intolerance allergy imidazole triazoles , nonazole component clotrimazole troche ( dextrose , cellulose , povidone , magnesium stearate ) . Moderate severe liver disease define specify lab value . Concurrent Medication : Excluded pending result phase I study determine whether interaction fluconazole agent occur : Barbiturates . Phenytoin . Coumarintype anticoagulant . Rifampin . Oral hypoglycemics . Cyclosporin . Patients follow excluded : Known history intolerance allergy imidazole triazoles , nonazole component clotrimazole troche ( dextrose , cellulose , povidone , magnesium stearate ) . Unable tolerate oral medication . Moderate severe liver disease define specify lab value . Life expectancy &lt; 4 week . Unable unwilling follow center conduct study . Prior Medication : Excluded within 3 day study entry : Other antifungal agent . Excluded pending result phase I study determine whether interaction fluconazole agent occur : Barbiturates . Phenytoin . Coumarintype anticoagulant . Rifampin . Oral hypoglycemics . Cyclosporin . Patients meet CDC criterion diagnosis AIDS , serologic virologic evidence HIV infection ( without AIDSdefining opportunistic infection yet ) . Patients give informed consent write participation study . Patients sign oropharyngeal candidiasis , i.e. , typical white plaque .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 1990</verification_date>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Fluconazole</keyword>
	<keyword>Clotrimazole</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Candidiasis , Oral</keyword>
</DOC>